Brain-computer interface startups are surging — and poised to expand technologically and geographically. After early ...
In a remarkable leap forward for neuroscience and technological innovation, Elon Musk's brain implant company Neuralink has officially received approval from the FDA to begin the first human trials of ...
The pharmaceutical and medical device industries stand at an inflection point. After decades of reliance on traditional randomized controlled trials (RCTs), computational modeling and simulation (CM&S ...
Clinical trial coordinators and healthcare providers can use the technology to automatically monitor patient medication adherence in real-time. Using their smartphones or tablets, patients are alerted ...
Please provide your email address to receive an email when new articles are posted on . The computer platform MatchMiner helps clinicians and researchers identify potential matches between patients ...
Before a drug or medical device is approved for use in humans, it must undergo a clinical trial. Clinical trials ultimately aim to answer two simple questions: is the drug or device safe? And does it ...
Elon Musk might be well positioned in space travel and electric vehicles, but the world's second-richest person is taking a backseat when it comes to a brain-computer interface (BCI). New York-based ...
As more patients with cancer have their tumors genomically profiled, and more therapies targeting genomic alterations enter clinical trials, the task of connecting patients to trials for which they ...
Professor of medicine at Flinders University Nikolai Petrovsky and lead researcher on the vaccine said that to his knowledge, a flu vaccine developed with artificial intelligence had not advanced to ...
The latest version of the wireless standard, Wi-Fi 7, promises faster speeds, enhanced security, and improved performance and user experience, but to date, adoption across enterprises has been ...
Researchers are using computer models to simulate COVID-19 infections on a cellular level which allows for virtual trials of drugs and vaccines, opening the possibility of pre-assessment for drug and ...